Joint Venture Between Schulman Associates IRB and Falcon Consulting Group
Schulman Associates IRB, Inc. and Falcon Consulting Group, LLC announced they have formed a joint venture
Schulman Associates IRB, Inc. and Falcon Consulting Group, LLC announced they have formed a joint venture, Provision Research Compliance Services. By combining the GCP quality assurance expertise from Falcon with the Human Research Protection of Schulman, the new entity will offer these joint global consultancy services. The companies believe that an alignment of GCP and HRP practices will provide essential global regulatory compliance and significantly improve the performance of clinical studies.
Read the full release here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
